Andrew Michael Strand, MD | |
800 Washington St, Boston, MA 02111 | |
(617) 636-5000 | |
Not Available |
Full Name | Andrew Michael Strand |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 12 Years |
Location | 800 Washington St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225395379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 275209 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tufts Medical Center | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pratt Medical Group Inc | 3375515661 | 265 |
News Archive
Two recently discovered genetic differences between brain cancer cells and normal tissue cells - an altered gene and a snippet of noncoding genetic material - could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.
New University of Minnesota Medical School research evaluates the impact of multimorbidity on the probability of hip fractures.
Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.
The European Commission has licensed Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).
› Verified 9 days ago
Entity Name | Pratt Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
Two recently discovered genetic differences between brain cancer cells and normal tissue cells - an altered gene and a snippet of noncoding genetic material - could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.
New University of Minnesota Medical School research evaluates the impact of multimorbidity on the probability of hip fractures.
Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.
The European Commission has licensed Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew Michael Strand, MD 800 Washington St, Boston, MA 02111-1552 Ph: (617) 636-5000 | Andrew Michael Strand, MD 800 Washington St, Boston, MA 02111 Ph: (617) 636-5000 |
News Archive
Two recently discovered genetic differences between brain cancer cells and normal tissue cells - an altered gene and a snippet of noncoding genetic material - could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.
New University of Minnesota Medical School research evaluates the impact of multimorbidity on the probability of hip fractures.
Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.
The European Commission has licensed Avastin in combination with standard chemotherapy for the treatment of women with advanced cervical cancer. Until now, the treatment has been available ahead of licence to eligible patients in England via individual requests to the Cancer Drugs Fund (CDF).
› Verified 9 days ago
Kaitlyn My-tu Lam, MBBS Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |